05/07/2021
4:09 PM | BlackRock Inc. (Filed by)
Checkpoint Therapeutics (Subject)
| Form SC 13G/A
| |
05/06/2021
3:31 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2021
5:10 AM | Checkpoint Therapeutics (Filer)
| Form DEFA14A
| |
04/30/2021
5:08 AM | Checkpoint Therapeutics (Filer)
| Form DEF 14A
| |
04/20/2021
3:16 PM | Checkpoint Therapeutics (Filer)
| Form PRE 14A
| |
03/12/2021
7:35 AM | Checkpoint Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/09/2021
4:17 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2021
7:16 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2021
7:16 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2021
8:18 AM | Checkpoint Therapeutics (Subject)
SABBY MANAGEMENT, LLC (Filed by)
| Form SC 13G/A
| |
|
12/23/2020
8:30 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2020
11:15 PM | Checkpoint Therapeutics (Filer)
| Form EFFECT
| |
12/17/2020
4:20 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/17/2020
4:18 PM | Checkpoint Therapeutics (Filer)
| Form 424B5
| |
11/27/2020
4:16 PM | Checkpoint Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/27/2020
3:03 PM | Checkpoint Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/06/2020
3:11 PM | Checkpoint Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2020
3:31 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/07/2020
4:28 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2020
9:08 AM | Checkpoint Therapeutics (Subject)
CVI Investments, Inc. (Filed by)
| Form SC 13G
| |
09/21/2020
4:26 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/21/2020
4:02 PM | Checkpoint Therapeutics (Filer)
| Form 424B5
| |
09/18/2020
9:10 AM | Checkpoint Therapeutics (Subject)
SABBY MANAGEMENT, LLC (Filed by)
| Form SC 13G
| |
09/17/2020
4:25 PM | Checkpoint Therapeutics (Filer)
| Form 424B5
| |
09/17/2020
4:15 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2020
5:39 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2020
3:30 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2020
7:40 AM | Checkpoint Therapeutics (Filer)
| Form DEFA14A
| |
04/24/2020
8:01 AM | Checkpoint Therapeutics (Filer)
| Form DEFA14A
| |
04/24/2020
8:00 AM | Checkpoint Therapeutics (Filer)
| Form DEF 14A
| |
04/21/2020
7:31 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2020
4:14 PM | Checkpoint Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/25/2020
6:01 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2020
6:01 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2019
12:22 PM | BlackRock Inc. (Filed by)
Checkpoint Therapeutics (Subject)
| Form SC 13G/A
| |
11/22/2019
7:00 AM | Checkpoint Therapeutics (Issuer)
ROSENWALD LINDSAY A MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2019
7:31 AM | Checkpoint Therapeutics (Filer)
| Form 424B5
| |
11/20/2019
3:50 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/19/2019
4:26 PM | Checkpoint Therapeutics (Filer)
| Form 424B5
| |
11/07/2019
3:45 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2019
4:01 PM | Checkpoint Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2019
3:35 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2019
3:50 PM | Checkpoint Therapeutics (Issuer)
WEISS MICHAEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2019
3:49 PM | Checkpoint Therapeutics (Issuer)
SALZMAN BARRY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2019
3:48 PM | Checkpoint Therapeutics (Issuer)
ROSENWALD LINDSAY A MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2019
3:47 PM | Checkpoint Therapeutics (Issuer)
Herskowitz Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2019
3:46 PM | Boilen Scott (Reporting)
Checkpoint Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2019
3:46 PM | Bechon Christian (Reporting)
Checkpoint Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2019
4:17 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2019
5:59 AM | Checkpoint Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2019
4:13 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2019
6:45 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2019
5:34 AM | Checkpoint Therapeutics (Filer)
| Form DEFA14A
| |
04/30/2019
5:30 AM | Checkpoint Therapeutics (Filer)
| Form DEF 14A
| |
04/25/2019
4:01 PM | Checkpoint Therapeutics (Filer)
| Form CT ORDER
| |
04/19/2019
3:19 PM | Checkpoint Therapeutics (Subject)
Fortress Biotech, Inc. (Filed by)
| Form SC 13D/A
| |
03/15/2019
6:40 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2019
3:31 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2019
3:30 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2018
11:23 AM | Checkpoint Therapeutics (Issuer)
ROSENWALD LINDSAY A MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2018
3:32 PM | Checkpoint Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/02/2018
7:33 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/19/2018
3:31 PM | Bechon Christian (Reporting)
Checkpoint Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/16/2018
4:01 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2018
6:31 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2018
3:42 PM | Checkpoint Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/15/2018
4:26 PM | Boilen Scott (Reporting)
Checkpoint Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2018
4:25 PM | Checkpoint Therapeutics (Issuer)
Herskowitz Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2018
4:23 PM | Checkpoint Therapeutics (Issuer)
ROSENWALD LINDSAY A MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2018
4:22 PM | Checkpoint Therapeutics (Issuer)
SALZMAN BARRY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2018
4:21 PM | Checkpoint Therapeutics (Issuer)
WEISS MICHAEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2018
3:43 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2018
3:43 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2018
3:20 PM | Checkpoint Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/30/2018
6:02 AM | Checkpoint Therapeutics (Filer)
| Form DEFA14A
| |
04/30/2018
6:01 AM | Checkpoint Therapeutics (Filer)
| Form DEF 14A
| |
04/20/2018
6:01 AM | Checkpoint Therapeutics (Filer)
| Form PRE 14A
| |
03/16/2018
7:01 AM | Checkpoint Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/15/2018
3:14 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/08/2018
4:21 PM | Checkpoint Therapeutics (Filer)
| Form 424B5
| |
03/07/2018
3:02 PM | Checkpoint Therapeutics (Filer)
| Form 424B5
| |
02/01/2018
5:41 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2018
5:40 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2017
11:15 PM | Checkpoint Therapeutics (Filer)
| Form EFFECT
| |
